Keyword: Biotechnology

News

J&J Expects Actelion Deal to Close This Week

13.06.2017 - The European Commission has approved plans by US healthcare group Johnson & Johnson to acquire Swiss biotech Actelion, thus completing all global regulatory approvals. J&J said it...

News

Bicycle Gains Funds for Cancer Drug Trials

01.06.2017 - UK biotech Bicycle Therapeutics has raised £40 million from a Series B financing round to advance the development of multiple candidate drugs to treat cancers with a high unmet...

News

UK Leads European Biotech Funding

01.06.2017 - A new report released by the UK BioIndustry Association (BIA) showed that the UK received the highest amount of biotech funding compared to anywhere else in Europe last year, and...

News

Biogen Licenses Remedy’s Stroke Drug

19.05.2017 - Biogen has licensed a late-stage stroke drug from Remedy Pharmaceuticals. The US biotech will make an upfront payment of $120 million for Cirara (intravenous glyburide), as well as...

News

South Africa Conditionally Approves Bayer-Monsanto

08.05.2017 - South Africa’s competition commission has conditionally approved Bayer’s plan to acquire Monsanto, thus becoming the first antitrust authority to do so. It will require divestments...

Markets & Companies

China’s Investors Advance

27.04.2017 - Chinese outbound foreign investment continues to beat records year by year. The Asian powerhouse is investing in overseas markets to acquire advanced technology, know-how and...

News

Trump Chooses Gottlieb to Head FDA

14.03.2017 - US President Donald Trump has chosen Scott Gottlieb to head the Food and Drug Administration. The 44-year-old former physician, who served as deputy FDA commissioner of medical and...

News

Biotech Chiefs Lambaste Trump’s Travel Ban

09.02.2017 - Chief executives of more than 160 biotechnology companies have written an open letter to scientific journal Nature Biotechnology, expressing their “deep concern and opposition” to...